Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01979523Phase 2Active Not Recruiting
Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma
Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7
PrincipalinvestigatorStart date: 2013-11-21
NCT01587352Phase 2Active Not Recruiting
Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Metastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7
PrincipalinvestigatorStart date: 2012-05-29

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Memorial Sloan Kettering Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David H Lawson

Eastern Cooperative Oncology Group

Related
1 trials

Shared therapeutic areas:

Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Jason J Luke

Alliance for Clinical Trials in Oncology

Related
2 trials

Shared therapeutic areas:

Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Sapna Patel

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Metastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Sapna Patel

University of Texas MD Anderson Cancer Center LAO

Related
1 trials

Shared therapeutic areas:

Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Lars Ny

Department of Oncology, Sahlgrenska University Hospital, Sweden

Related
1 trials

Shared therapeutic areas:

Metastatic Uveal Melanoma
Similarity Score10%

Craig Slingluff

Cancer Immunotherapy Trials Network

Related
1 trials

Shared therapeutic areas:

Recurrent Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Sylvie DOLBEAULT, PHD

Institut Curie

Related
1 trials

Shared therapeutic areas:

Metastatic Uveal Melanoma
Similarity Score10%

Lauren Banks, MD, PhD

Memorial Sloan Kettering Cancer Center

Related
1 trials

Shared therapeutic areas:

Metastatic Uveal Melanoma

Worked with same sponsors:

Memorial Sloan Kettering Cancer Center
Similarity Score10%

Sarah Reilly, MD

Foghorn Therapeutics

Related
3 trials

Shared therapeutic areas:

Metastatic Uveal Melanoma
Similarity Score10%

Anne BREDART, PHD

Institut Curie

Related
1 trials

Shared therapeutic areas:

Metastatic Uveal Melanoma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01979523Phase 2PrincipalInvestigator

Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma

Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7
Active Not Recruiting
NCT01587352Phase 2PrincipalInvestigator

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

Metastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7
Active Not Recruiting

All 2 trials loaded